Updated

A growing number of lawsuits allege that GLP-1 weight-loss and diabetes drugs can cause serious harms such as blindness or pancreatitis, but scant systematic data on serious adverse effects is making it difficult to answer both the scientific and legal questions about how often such harms actually occur.